π¦
|
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
13 auth.
H. Dietz,
Carry R. Cutting,
R. Pyeritz,
C. Maslen,
L. Sakai,
G. Corson,
E. Puffenberger,
A. Hamosh,
E. Nanthakumar,
S. Curristin,
...
G. Stetten,
D. Meyers,
C. Francomano
|
10 |
1991 |
10 π¦
|
π
|
The revised Ghent nosology for the Marfan syndrome
14 auth.
B. Loeys,
H. Dietz,
A. Braverman,
B. Callewaert,
J. De Backer,
R. Devereux,
Y. Hilhorst-Hofstee,
G. Jondeau,
L. Faivre,
D. Milewicz,
...
R. Pyeritz,
P. Sponseller,
Paul Wordsworth,
A. De Paepe
|
10 |
2010 |
10 π
|
π’
|
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
20 auth.
J. Habashi,
D. Judge,
Tammy M. Holm,
R. Cohn,
B. Loeys,
T. Cooper,
Loretha A Myers,
E. C. Klein,
Guosheng Liu,
C. Calvi,
...
Megan Podowski,
E. Neptune,
M. Halushka,
D. Bedja,
K. Gabrielson,
D. Rifkin,
L. Carta,
F. Ramirez,
D. Huso,
H. Dietz
|
10 |
2006 |
10 π’
|
π¬
|
Revised diagnostic criteria for the Marfan syndrome.
A. De Paepe,
R. B. Devereux,
H. Dietz,
R. Hennekam,
R. Pyeritz
|
10 |
1996 |
10 π¬
|
π’
|
Aneurysm Syndromes Caused by Mutations in the TGF-Ξ² Receptor
21 auth.
B. Loeys,
U. Schwarze,
Tammy M. Holm,
B. Callewaert,
G. Thomas,
H. Pannu,
J. De Backer,
Gretchen L. Oswald,
S. Symoens,
S. Manouvrier,
...
A. Roberts,
F. Faravelli,
M. Greco,
R. Pyeritz,
D. Milewicz,
P. Coucke,
D. Cameron,
A. Braverman,
P. Byers,
A. De Paepe,
H. Dietz
|
10 |
2006 |
10 π’
|
π’
|
Dysregulation of TGF-Ξ² activation contributes to pathogenesis in Marfan syndrome
9 auth.
E. Neptune,
P. Frischmeyer,
D. Arking,
Loretha A Myers,
T. Bunton,
B. Gayraud,
...
F. Ramirez,
L. Sakai,
H. Dietz
|
10 |
2003 |
10 π’
|
π’
|
Nonsense-mediated mRNA decay in health and disease.
P. Frischmeyer,
H. Dietz
|
10 |
1999 |
10 π’
|
π’
|
Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise
J. Mendell,
N. Sharifi,
J. Meyers,
F. MartΓnez-Murillo,
H. Dietz
|
9 |
2004 |
9 π’
|
π’
|
Aneurysm syndromes caused by mutations in the TGF-beta receptor.
21 auth.
B. Loeys,
U. Schwarze,
Tammy M. Holm,
B. Callewaert,
G. Thomas,
H. Pannu,
J. De Backer,
Gretchen L. Oswald,
S. Symoens,
S. Manouvrier,
...
A. Roberts,
F. Faravelli,
M. Greco,
R. Pyeritz,
D. Milewicz,
P. Coucke,
D. Cameron,
A. Braverman,
P. Byers,
A. De Paepe,
H. Dietz
|
9 |
2006 |
9 π’
|
π’
|
Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.
9 auth.
E. Neptune,
P. Frischmeyer,
D. Arking,
Loretha A Myers,
T. Bunton,
B. Gayraud,
...
F. Ramirez,
L. Sakai,
H. Dietz
|
9 |
2003 |
9 π’
|
π’
|
Angiotensin II type 1 receptor blockade attenuates TGF-Ξ²βinduced failure of muscle regeneration in multiple myopathic states
14 auth.
R. Cohn,
C. V. Erp,
J. Habashi,
A. Soleimani,
E. C. Klein,
Matthew T. Lisi,
Matthew Gamradt,
C. Rhys,
Tammy M. Holm,
B. Loeys,
...
F. Ramirez,
D. Judge,
C. Ward,
H. Dietz
|
9 |
2007 |
9 π’
|
π’
|
Marfan's syndrome
D. Judge,
H. Dietz
|
9 |
2005 |
9 π’
|
π¬
|
Exosome-Mediated Recognition and Degradation of mRNAs Lacking a Termination Codon
A. van Hoof,
P. Frischmeyer,
H. Dietz,
R. Parker
|
9 |
2002 |
9 π¬
|